Skip to main content

Table 1 Demographics of subjects (a) and their nodule characteristics (b)

From: Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study

 

N = 37

a

Patient characteristics

Cohort

 AEGIS I/II

30 (81%)

 Percepta registry

7 (19%)

Age

 Years (median (IQR))

73 (68,77)

Race

 White

28 (76%)

 Black

8 (22%)

 Asian

1 (2.7%)

Sex

 Female

17 (46%)

 Male

20 (54%)

Smoking status

 Current smoker

19 (51%)

 Former smoker

18 (49%)

Tobacco pack years

 Years (median (IQR))

59 (40,82)

b

Nodule characteristics

Nodule size (mm)

 Median (IQR)

23 (18,25)

Nodule location

 Central

17 (46%)

 Peripheral

20 (54%)

Lung cancer (histologic type)

 Malignant

35 (95%)

  Non-small cell

30 (81%)

   Adenocarcinoma

13 (35%)

   Squamous

8 (22%)

   Not specified/unknown

9 (24%)

  Small cell (Limited stage)

2 (5%)

  Unknown

3 (8%)

 Benign

2 (5%)